PRMT5 mediated FUBP1 methylation accelerates prostate cancer progression.
Yan W, Liu X, Qiu X, Zhang X, Chen J, Xiao K, Wu P, Peng C, Hu X, Wang Z, Qin J, Sun L, Chen L, Wu D, Huang S, Yin L, Li Z.
Yan W, et al. Among authors: xiao k.
J Clin Invest. 2024 Aug 15:e175023. doi: 10.1172/JCI175023. Online ahead of print.
J Clin Invest. 2024.
PMID: 39146021
Free article.